Stockreport

Vir Biotechnology to Participate in the BofA Securities Healthcare Conference 2024

Vir Biotechnology, Inc.  (VIR) 
PDF SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that Marianne De Backer, M.Sc., Ph.D., MBA, Chief Executive Officer is schedule [Read more]